Related Experiment Videos
Implantable injection port for epidural opiates self-administration
Acta Anaesthesiologica Belgica
|January 1, 1984
Summary
This study demonstrates that self-administering epidural morphine via an implantable port effectively manages cancer pain. Patients experienced good pain relief with rare side effects, enabling outpatient care.
Area of Science:
- Oncology
- Pain Management
- Neurosurgery
Background:
- Cancer pain significantly impacts patient quality of life.
- Epidural analgesia is a recognized method for severe pain management.
- Outpatient management of cancer pain requires effective and safe delivery systems.
Purpose of the Study:
- To evaluate the efficacy and safety of self-administered epidural opiates for cancer pain relief on an outpatient basis.
- To assess the feasibility of using an implantable port system for continuous epidural drug delivery in cancer patients.
Main Methods:
- Percutaneous epidural catheter insertion followed by a 24-hour observation period with morphine sulfate.
- Placement of an implantable subcutaneous port connected to the epidural space via a silastic catheter.
- Comprehensive patient training for self-administration and outpatient follow-up in an oncologic consultation unit.
Main Results:
- Successful pain relief was achieved in patients managed with the implantable port system.
- Side effects associated with epidural opiate administration were infrequent.
- The method allowed for effective outpatient management of cancer pain.
Conclusions:
- Implantable port-based epidural opiate self-administration is a valuable approach for managing cancer pain.
- This method requires rigorous technique and thorough patient training for optimal outcomes.
- Outpatient epidural analgesia can improve quality of life for cancer patients experiencing severe pain.